PREFERENCE: 12-week open label trial on olanzapine orodispersible tablet vs. oral olanzapine preference study

Trial Profile

PREFERENCE: 12-week open label trial on olanzapine orodispersible tablet vs. oral olanzapine preference study

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Olanzapine (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms PREFERENCE
  • Sponsors Eli Lilly
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 Jul 2010 Results published in World Journal of Biological Psychiatry.
    • 23 Jan 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top